These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33301729)

  • 21. Post COVID-19 fungal and microbial infections.
    Balaji SM
    Indian J Dent Res; 2020; 31(5):669. PubMed ID: 33433501
    [No Abstract]   [Full Text] [Related]  

  • 22. Practical measures for SARS-CoV-2 infection prevention - Authors' reply.
    Llibre JM; Martin-Iguacel R; Revollo B
    Lancet Infect Dis; 2022 Jan; 22(1):21. PubMed ID: 34953549
    [No Abstract]   [Full Text] [Related]  

  • 23. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
    Voysey M; Pollard AJ
    Lancet; 2020 Nov; 396(10261):1486-1487. PubMed ID: 33160565
    [No Abstract]   [Full Text] [Related]  

  • 24. COVID Induced Functional Exhaustion and Persistently Reduced Lymphocytes as Vital Contributing Factors for Post-COVID Rhino-orbital and Cerebral Mucormycosis in Patients with Diabetes: Report from the Indian Sub-continent.
    Bhargava D; Ahirwal R; Dubey S; Gurjar P; Pandey A; Beena S; Koneru G
    Head Neck Pathol; 2022 Sep; 16(3):645-650. PubMed ID: 34751896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropathology associated with SARS-CoV-2 infection - Authors' reply.
    von Weyhern CH; Kaufmann I; Neff F; Kremer M
    Lancet; 2021 Jan; 397(10271):277-278. PubMed ID: 33485447
    [No Abstract]   [Full Text] [Related]  

  • 26. Provision of holistic care after severe COVID-19 pneumonia - Authors' reply.
    D'Cruz RF; Perrin F; Jolley CJ; Waller MD
    Lancet Respir Med; 2021 Mar; 9(3):e25. PubMed ID: 33556318
    [No Abstract]   [Full Text] [Related]  

  • 27. Letter: SARS-CoV-2 induced gastrointestinal inflammation-authors' reply.
    Taxonera C; Alba C
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1750-1751. PubMed ID: 33205880
    [No Abstract]   [Full Text] [Related]  

  • 28. SARS-CoV-2 seroprevalence in Spain - Authors' reply.
    Pollán M; Pérez-Gómez B; Pastor-Barriuso R; Oteo J; Pérez-Olmeda M; Yotti R;
    Lancet; 2020 Nov; 396(10261):1484-1485. PubMed ID: 33160561
    [No Abstract]   [Full Text] [Related]  

  • 29. Authors' Reply.
    Farkash EA; Wilson AM; Jentzen JM
    J Am Soc Nephrol; 2020 Sep; 31(9):2225-2226. PubMed ID: 32792369
    [No Abstract]   [Full Text] [Related]  

  • 30. Using EM data to understand COVID-19 pathophysiology - Authors' reply.
    Dittmayer C; Meinhardt J; Radbruch H; Radke J; Heppner BI; Heppner FL; Stenzel W; Holland G; Laue M
    Lancet; 2021 Jan; 397(10270):197-198. PubMed ID: 33453781
    [No Abstract]   [Full Text] [Related]  

  • 31. Authors' Reply to Cattaneo et al.: "Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6".
    Cojutti PG; Londero A; Della Siega P; Givone F; Fabris M; Biasizzo J; Tascini C; Pea F
    Clin Pharmacokinet; 2021 Jun; 60(6):833-834. PubMed ID: 33864624
    [No Abstract]   [Full Text] [Related]  

  • 32. COVID-19 and the difficulty of inferring epidemiological parameters from clinical data - Authors' reply.
    Verity R; Okell L; Dorigatti I; Winskill P; Whittaker C; Walker P; Donnelly C; Ferguson N; Ghani A
    Lancet Infect Dis; 2021 Jan; 21(1):28. PubMed ID: 32473660
    [No Abstract]   [Full Text] [Related]  

  • 33. The promise of COVID-19 vaccines. Authors' reply.
    Sokolska JM; Kurcz J; Kosmala W
    Kardiol Pol; 2022; 80(1):111-112. PubMed ID: 34981827
    [No Abstract]   [Full Text] [Related]  

  • 34. SARS-CoV-2 shedding and infectivity - Authors' reply.
    Zhou F; Fan G; Liu Z; Cao B
    Lancet; 2020 Apr; 395(10233):1340. PubMed ID: 32304646
    [No Abstract]   [Full Text] [Related]  

  • 35. Authors' reply.
    Baud D; Nielsen-Saines K; Qi X; Musso D; Pomar L; Favre G
    Lancet Infect Dis; 2020 Jul; 20(7):775-776. PubMed ID: 32243816
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of the COVID-19 Pandemic Associated Sleep Abnormalities in Children: Authors' Reply.
    Ferretti S; Lazzareschi I; Curatola A
    J Child Neurol; 2022 Dec; 37(12-14):1012-1013. PubMed ID: 36128791
    [No Abstract]   [Full Text] [Related]  

  • 37. Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran - Authors' reply.
    Darvishian M; Sharafkhah M; Poustchi H; Malekzadeh R
    Lancet Infect Dis; 2021 May; 21(5):604-605. PubMed ID: 33600756
    [No Abstract]   [Full Text] [Related]  

  • 38. COVID-19 in patients with HIV - Authors' reply.
    Miró JM; Ambrosioni J; Blanco JL
    Lancet HIV; 2020 Jun; 7(6):e383-e384. PubMed ID: 32416770
    [No Abstract]   [Full Text] [Related]  

  • 39. Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases - Authors' reply.
    Spinelli MA; Rutherford G; Gandhi M
    Lancet Infect Dis; 2021 Jul; 21(7):915-916. PubMed ID: 33864804
    [No Abstract]   [Full Text] [Related]  

  • 40. COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.
    Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E
    Lancet; 2021 Jun; 397(10291):2249-2250. PubMed ID: 34119061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.